These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 7731703)

  • 1. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers.
    Tornaletti S; Pfeifer GP
    Oncogene; 1995 Apr; 10(8):1493-9. PubMed ID: 7731703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
    Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
    Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma.
    Kouidou S; Agidou T; Kyrkou A; Andreou A; Katopodi T; Georgiou E; Krikelis D; Dimitriadou A; Spanos P; Tsilikas C; Destouni H; Tzimagiorgis G
    Lung Cancer; 2005 Dec; 50(3):299-307. PubMed ID: 16125822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of 5-methylcytosine in sunlight-induced mutagenesis.
    You YH; Li C; Pfeifer GP
    J Mol Biol; 1999 Oct; 293(3):493-503. PubMed ID: 10543945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers.
    Denissenko MF; Pao A; Pfeifer GP; Tang M
    Oncogene; 1998 Mar; 16(10):1241-7. PubMed ID: 9546425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Methylcytosine as an endogenous mutagen in the p53 tumor suppressor gene.
    Rideout WM; Coetzee GA; Olumi AF; Spruck CH; Jones PA
    Princess Takamatsu Symp; 1991; 22():207-19. PubMed ID: 1844242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for the involvement of DNA methylation in colon carcinogenesis.
    Schmutte C; Yang AS; Nguyen TT; Beart RW; Jones PA
    Cancer Res; 1996 May; 56(10):2375-81. PubMed ID: 8625314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation, mutation and cancer.
    Jones PA; Rideout WM; Shen JC; Spruck CH; Tsai YC
    Bioessays; 1992 Jan; 14(1):33-6. PubMed ID: 1546979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation and repeats in silent and nonsense mutations of p53.
    Kouidou S; Malousi A; Maglaveras N
    Mutat Res; 2006 Jul; 599(1-2):167-77. PubMed ID: 16620878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General implications for CpG hot spot mutations: methylation patterns of the human iduronate-2-sulfatase gene locus.
    Tomatsu S; Orii KO; Bi Y; Gutierrez MA; Nishioka T; Yamaguchi S; Kondo N; Orii T; Noguchi A; Sly WS
    Hum Mutat; 2004 Jun; 23(6):590-8. PubMed ID: 15146464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarities in sunlight-induced mutational spectra of CpG-methylated transgenes and the p53 gene in skin cancer point to an important role of 5-methylcytosine residues in solar UV mutagenesis.
    You YH; Pfeifer GP
    J Mol Biol; 2001 Jan; 305(3):389-99. PubMed ID: 11152598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of CpG methylation for solar UV-induced mutagenesis and carcinogenesis in skin.
    Ikehata H; Ono T
    Photochem Photobiol; 2007; 83(1):196-204. PubMed ID: 16620158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis.
    Esteller M; Risques RA; Toyota M; Capella G; Moreno V; Peinado MA; Baylin SB; Herman JG
    Cancer Res; 2001 Jun; 61(12):4689-92. PubMed ID: 11406538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage and mutations produced by chloroacetaldehyde in a CpG-methylated target gene.
    Choi JH; Pfeifer GP
    Mutat Res; 2004 Dec; 568(2):245-56. PubMed ID: 15542111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
    Besaratinia A; Bates SE; Pfeifer GP
    Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
    Hu W; Feng Z; Tang MS
    Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots.
    Chen JX; Zheng Y; West M; Tang MS
    Cancer Res; 1998 May; 58(10):2070-5. PubMed ID: 9605744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations.
    Shahedian B; Shi Y; Zou M; Farid NR
    Mol Genet Metab; 2001 Feb; 72(2):155-63. PubMed ID: 11161841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumors associated with p53 germline mutations: a synopsis of 91 families.
    Kleihues P; Schäuble B; zur Hausen A; Estève J; Ohgaki H
    Am J Pathol; 1997 Jan; 150(1):1-13. PubMed ID: 9006316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.